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Abstract
Objective—To describe self-reported practice patterns of PCPs for the diagnosis, treatment, and 
management of men with CP/CPPS.
Methods—556 PCPs in Boston, Chicago, and Los Angeles were presented a vignette, which 
described a man with typical CP/CPPS symptoms, followed by questions about CP/CPPS.
Results—The response rate was 52%. Only 62 percent of respondents reported ever seeing a 
patient like the one described in the vignette. Fully 16% of respondents were “not at all” familiar 
with CP/CPPS, and 48% were “not at all” familiar with the NIH classification scheme for 
prostatitis. PCPs reported practice patterns regarding diagnosis and treatment of CP/CPPS, which 
are not supported by evidence.
Conclusions—Although studies suggest that CP/CPPS is common, many PCPs reported little or 
no familiarity, important knowledge deficits, and limited experience in managing men with this 
syndrome.
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INTRODUCTION
The term “prostatitis” is used to describe several conditions, including well-defined acute 
and chronic bacterial infections, poorly defined chronic pelvic pain syndrome, and 
asymptomatic inflammation in the prostate identified in pathology specimens. To limit 
confusion, the National Institutes of Health (NIH) developed a classification system and 
definitions for the prostatitis syndromes (1) (Table 1).
Although literature reviews provide compelling evidence that histologic prostatitis is 
common (2, 3), symptomatic, clinically-evident prostatitis is of greater importance to the 
patient and physician. The prevalence of current prostatitis-like symptoms (4, 5) or a 
previous physician’s diagnosis of prostatitis (6) is about 10%.
This study focuses on the predominant type of prostatitis, NIH Category III or chronic 
prostatitis/chronic pelvic pain syndrome (CP/CPPS). CP/CPPS is a common(7), bothersome 
condition among men of all ages that impairs health-related quality of life(8, 9) and has a 
substantial economic impact (10, 11). The hallmark of CP/CPPS is pelvic area pain (12). 
The NIH Chronic Prostatitis Symptom Index (NIH-CPSI) (Figure) is a reliable, valid, self-
administered index that measures symptoms of chronic prostatitis and their impact on daily 
life (13).
Although patients with CP/CPPS have traditionally been managed by urologists, many 
present first to primary care physicians with symptoms suggestive of CP/CPPS. 
Nonetheless, few studies (14–16) have examined what is known about primary care 
physicians’ practice patterns regarding CP/CPPS. To ascertain the knowledge, attitudes, and 
beliefs of primary care physicians about the diagnosis and treatment of CP/CPPS, we 
conducted a multi-center survey of primary care physicians in 2006.
METHODS
Study Sample
There was a convenience sample of 556 practicing primary care physicians who were 
eligible for the study at the participating institutions (Massachusetts General Hospital 
(MGH), Brigham and Women’s Hospital (BWH), University of California Los Angeles 
(UCLA), and Access Community Health Network (Access)). Access, located in Chicago, is 
the largest federally qualified health center organization in the United States. Lists of 
affiliated primary care physicians were obtained from the participating institutions, and 
these lists were refined using information provided by the General Medicine Divisions and 
the hospital directories to exclude physicians without direct patient care, residents and 
fellows, and those seeing only pediatric patients. A current interoffice mailing address was 
obtained for each physician.
Study Design
The Institutional Review Board of each institution approved the study and survey. Brief 
(<15 minutes), self-administered, pre-tested questionnaires were mailed to 556 physicians at 
the 3 institutions. The mailing included a cover letter from the Principal Investigator, a fact 
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sheet describing the study, a $5 coffee gift card, and a pre-stamped, pre-addressed return 
envelope. About 2 weeks after the initial mailing, all physicians were mailed a brief 1-page 
thank you/reminder letter. Nonrespondents were sent a second complete packet about 3 
weeks after the initial mailing. No further attempts to contact nonrepondents were made. 
Voluntary completion and return of the survey implied informed consent.
Questionnaire Development
A literature review identified 3 survey studies of primary care physicians regarding CP/
CPPS as a starting point in questionnaire development (14–16). Across the study sites of 
Boston, Chicago, and Los Angeles, we conducted a series of 5 primary care physician focus 
groups and subsequently drafted a preliminary questionnaire. The draft questionnaire was 
modified after several cognitive interviews with primary care physicians across the 3 study 
sites. The modified questionnaire was then pre-tested (with primary care physicians as well 
as a panel of 5 experts in CP/CPPS from North America) and refined following the 
debriefing. The finalized questionnaire (Appendix) included 5 domains; familiarity and 
experience with CP/CPPS, diagnosis (which included referral threshold), treatment, 
perceptions on managing patients with CP/CPPS (which included knowledge questions), and 
demographics. A vignette was presented and used to “anchor” responses to questions 
regarding how the physicians would evaluate and treat such a patient. The vignette read as 
follows:
A healthy 38-year old man reports several months of nonspecific perineal pain and urinary 
frequency. He is in a longstanding, monogamous relationship and has no history of STDs or 
UTIs. His prostate examination is normal. His urinalysis is normal and his urine culture is 
negative.
For analytic purposes, diagnostic tests and treatment recommendations were stratified into 
common (at least 50% of respondents do it “more than half the time” or “almost always”) 
and uncommon (at least 50% obtain a test “rarely” or “never” and recommend treatment to 
“very few” or “none”).
Statistical Analyses
This was a descriptive, cross-sectional study, which utilized questionnaires to obtain 
pertinent data. The completed questionnaires were keyed into a data entry system, and 
double blind data entry provided 100% verification of coding and data entry. Analyses 
involved primarily the generation of descriptive statistics with appropriate confidence 
intervals. All analyses were performed at the data center (at the University of Illinois, 
Chicago) and utilized Statistical Package for the Social Sciences version 15 (17).
Sample size—As part of the questionnaire development process, a set of correct answers 
was identified related to basic knowledge about CP/CPPS, and the proportion of primary 
care physicians who provided correct responses was calculated for each question. A similar 
study evaluating practice patterns in primary care physicians for the diagnosis and treatment 
of benign prostatic hyperplasia (BPH) indicated that approximately one-third of these 
physicians followed all of the recommended guidelines (18). Because CP/CPPS is less 
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familiar to PCPs than BPH, we expected that a lower proportion (estimated at 25%) would 
demonstrate adequate knowledge. Assuming a 25% population prevalence of PCP correct 
responses and a 95% probability that the proportion obtained would be +/− 5% of the 
population value, the sample size required was calculated to be approximately 288 subjects.
Descriptives and Predictors of Primary Care Physicians’ Responses—
Descriptive statistics were used for all survey responses and physician characteristics. Chi-
square and ANOVA were performed to detect variation in having familiarity with the CP/
CPPS condition, its symptoms, and etiology based on physician demographic characteristics. 
Ability to identify symptoms of CP/CPPS and its etiology were considered as knowledge 
questions and responses were coded as correct and incorrect. Logistic regression analysis 
was used to predict which characteristics of primary care physicians were associated with 
the likelihood of performing various tests and recommending various treatments.
RESULTS
Sample characteristics
Among the 556 primary care physicians who were mailed the questionnaire, a total of 289 
(52%) responded, most of those (59%) from the initial mailing. Respondents were 
distributed approximately equally by gender (53% male), and the time from graduation from 
medical school was an average of 19 years (range 1–51). Respondent practice type was 
community-based (38%), hospital-based (40%), and private practice-based (22%) (Table 2).
Diagnosis of CP/CPPS
Only 62 percent (180/289) of respondents reported ever seeing a patient like the one 
described in the vignette. Those physicians had seen a mean of 3.2 patients like this (range 
0–50) over the past 12 months, and reported a mean of 3.4 patients in their practice with a 
CP/CPPS diagnosis (0–30). Responders were asked, “When evaluating a patient like the one 
in the vignette to confirm the diagnosis, or to rule out other causes of his symptoms, how 
often do you do the following…”; their responses to 9 items are shown in Table 3. We found 
that testing for Chlamydia and gonorrhea and ordering serum creatinine were common 
diagnostic tests (reported being used at least more than half the time in 86% and 59%, 
respectively), and that obtaining pre- and post- massage urine cultures, ordering abdominal/
pelvic CT scans, post void residuals, and prostate ultrasounds were all uncommon diagnostic 
tests (range of 61% to 70%, used rarely or never). Although testing for prostate specific 
antigen has not been shown to be helpful in the diagnosis of CP/CPPS(19, 20), 
approximately 50% of respondents reported ordering this test about half the time or more.
Treatment of CP/CPPS
Physicians were asked, “For how many of your patients like the one described in the 
vignette have you recommended treatment (either initial treatment or follow-up treatment) 
with…”; their response to the following 12 items are shown in Table 4. Antibiotics were a 
common treatment recommendation (72% recommending more than half the time or almost 
always), while prostate massage, pelvic floor physical therapy, 5- alpha reductase inhibitors, 
bladder analgesics, complementary/alternative therapies, narcotic pain medications, 
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anticonvulsants, antidepressants, and anticholinergics were all uncommon recommendations 
(range of 75% to 97%, treated very few or none). Despite being a common treatment 
recommendation, the use of antibiotics for the treatment of men with CP/CPPS is not 
supported by the evidence (21). Although the evidence for the use of alpha blockers is 
inconsistent (22), we found that 41% of respondents recommended this treatment about half 
the time or more. While not supported by evidence, NSAIDs are often considered an 
adjunctive medication and our results showed that 61% recommended anti-inflammatory 
medications about half the time or more.
Knowledge and Perception of Managing Patients with CP/CPPS
Fully 16% (46/289) were “not at all” familiar with CP/CPPS, and 48% (139/289) were “not 
at all” familiar with the NIH classification of prostatitis (1)(Table 5). Sixty five percent of 
respondents (188/289) correctly identified the hallmark symptom of CP/CPPS as pelvic 
pain. Regarding etiology, 71% (205/289) correctly indicated that the majority of cases of 
CP/CPPS were non-infectious; however, 37% (107/289) incorrectly indicated that it was 
caused by a sexually transmitted disease, and 36% (104/289) incorrectly indicated that it 
was caused by a psychiatric illness. (Table 5).
We also asked how frequently the PCPs manage patients with other chronic conditions that 
often have uncertain etiology (Table 6). While the majority of PCPs reported that they 
frequently manage patients with chronic low back pain, chronic headache, and irritable 
bowel syndrome, and almost a quarter of PCPs reported frequently managing patients with 
chronic fatigue syndrome, only about 5% reported frequently managing patients with CP/
CPPS.
Predictors of Primary Care Physicians’ Responses
Using univariate analyses, we show that there are certain physician characteristics that are 
significantly associated with the likelihood of (1) having familiarity with CP/CPPS in men 
(practice setting, male gender, more years of practice, and higher percentage of male 
patients); (2) having knowledge of the hallmark symptoms of CP/CPPS (male gender); and 
(3) having knowledge in managing patients with CP/CPPS (male gender, more years of 
practice, higher percentage of male patients). Table 7 presents only significant associations 
between physician characteristics and familiarity and knowledge questions.. In the 
multivariate analyses of primary care physicians’ characteristics and the likelihood of 
performing various tests and recommending various treatments, results of the logistic 
regression analysis did not predict any consistent pattern in reporting various tests and 
recommending various treatments.
DISCUSSION
Knowledge of physician practices, including approaches to diagnosis, treatment, and 
management of patients is fundamental to both the development and evaluation of 
continuing medical education, medical school curricula, and national educational programs. 
The emerging recognition of CP/CPPS as an important medical condition was the impetus 
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for us to survey the diagnostic, treatment, and management patterns of primary care 
physicians in the United States.
Our study showed that many PCPs reported little or no familiarity with CP/CPPS, have 
important knowledge deficits, and have limited experience in managing men with this 
syndrome. Over one-third of PCPs reported never having seen a patient like the one with 
CP/CPPS described in the vignette. PCPs reported practice patterns regarding diagnosis and 
treatment of CP/CPPS, which are not supported by evidence, such as ordering prostate-
specific antigen tests and prescribing antibiotics. In order to effectively diagnose and treat 
CP/CPPS, physicians need to understand the NIH classification system for prostatitis; 
however, PCPs reported little or no familiarity with this classification scheme.
Two previous survey studies done 10 and 15 years ago, respectively, were from Canada (16) 
and the Netherlands. The only study done in the United States, done 10 years ago, was from 
one county in the state of Wisconsin (15). Previous studies did not specifically ask primary 
care physicians about chronic prostatitis/chronic pelvic pain syndrome, but instead referred 
to “prostatitis” in general. We were particularly interested in surveying physicians about 
new cases of CP/CPPS, as this is an important current research area. It is unclear whether 
the management of men with newly diagnosed CP/CPPS should vary from men with 
longstanding, treatment refractory CP/CPPS. Unlike the previous studies, we used a clinical 
vignette to be certain that primary care physicians were aware that our questions pertained to 
men with a specific type of prostatitis, namely CP/CPPS.
While studies suggest that the symptoms of CP/CPPS are common in the community(11, 
23), and that 1% of all visits to primary care physicians are for the diagnosis “prostatitis”
(24), our data indicated that fully 38% (110/289) of PCPs reported never having seen a 
patient like the one with CP/CPPS described in the vignette. In addition, 16% (46/289) 
reported being “not at all” familiar with the condition, CP/CPPS. Furthermore, PCPs in our 
study reported infrequently managing men with CP/CPPS; they reported more frequently 
managing other chronic pain conditions, such as chronic headache, chronic fatigue 
syndrome, irritable bowel syndrome, and interstitial cystitis, which do not appear to have 
correspondingly higher population-based prevalence than CP/CPPS. Whether these findings 
represent a large pool of men with CP/CPPS who do not seek care or seek care directly from 
urologists, or whether men who visit primary care physicians may not volunteer their CP/
CPPS symptoms or PCPs may not feel comfortable discussing them cannot be determined 
from our survey. It is also possible that CPPS is less common than we think, as most visits 
for “prostatitis” identified in studies such as the National Ambulatory Medical Care Survey 
studies(24) may not reflect CP/CPPS. Lastly, it could be that our sample of PCPs for this 
study may not be truly representative of PCPs in the community.
Responding physicians also reported varying practice patterns regarding diagnosis, referral, 
and treatment, and reported important knowledge deficits. Approximately half of the 
physicians in our survey study were “not at all” familiar with the classification of prostatitis, 
which is a fundamental tenet to caring for men with CP/CPPS, and should be a key feature 
of any educational outreach efforts to PCPs. Our finding that almost one-third of primary 
care physicians did not correctly respond that the etiology of CP/CPPS is non-infectious, 
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coupled with the finding that antibiotics were (inappropriately) the most common prescribed 
therapy, also suggest an essential need to educate PCPs. Acute and chronic bacterial 
prostatitis, which are infectious diseases, need to be differentiated from chronic prostatitis/
chronic pelvic pain syndrome, which likely does not have an infectious etiology. In addition, 
approximately one-third of primary care physicians incorrectly reported that CP/CPPS is 
caused by psychiatric illness. Improved education of PCPs about CP/CPPS may help change 
this potentially damaging perception that the chronic pelvic pain in men is psychogenic. 
Finally, there is a potential for harm (i.e., unnecessary anxiety, prostate biopsies) to men 
with symptoms suggestive of CP/CPPS by the inappropriate ordering of PSA tests, which 
our study showed was a common practice, yet there is no evidence to support this 
practice(19, 20).
Understandably a big challenge to managing men with CP/CPPS remains the fact that there 
is neither a gold standard diagnostic test nor proven effective treatment (25); therefore, there 
lacks an evidence-based clinical guideline to help primary care physicians in the 
management of this condition. Meanwhile, ongoing clinical trials funded by the NIDDK 
seek to identify new and effective treatments for men with CP/CPPS (www.uppcrn.org). 
Research is also underway to elucidate the natural history, etiology, and pathophysiology of 
this condition, such that early identification and intervention in primary care may result in 
improved outcomes for patients.
Another reason for educating primary care patients about CP/CPPS is that this condition is 
among those that cause chronic nonmalignant pain, an important new topic in primary care 
medicine (26). Since most primary care physicians are not comfortable treating patients with 
chronic nonmalignant pain, educational efforts are underway to increase PCPs’ willingness 
to manage patients with chronic pain. Educational efforts about chronic pelvic pain 
syndrome in men could serve as a useful model of a chronic nonmalignant pain condition, 
during medical training, including medical school, residency, fellowship, and continuing 
medical education courses.
Our study has several limitations. First, although our response rate of 52% is typical of 
physician surveys(27), response bias is a possibility. Secondly, our study population was 
chosen by convenience sampling, therefore, our findings warrant replication in a larger, 
more representative sample. Thirdly, the data on the practice patterns of PCPs were based on 
physician self-report and may not match actual practice. Fourthly, the associations between 
the physician characteristics and management practices must be viewed with caution, given 
that multiple tests of association were performed.
In conclusion, the results of this multi-center, primary care physician survey study suggest 
that educational efforts on the care of patients with CP/CPPS should target PCPs, especially 
since pain is now considered the hallmark symptom of this syndrome and diagnosis, 
treatment, and management of chronic nonmalignant pain in primary care practice has 
become a national health care priority.
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Figure. 
The NIH Chronic Prostatitis Symptom Index (13).
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Table 1
Categories of the Prostatitis Syndromes, According to the NIH Classification System(20).
Category Symptoms
I. Acute bacterial prostatitis Associated with severe symptoms of prostatitis, systemic infection, and acute bacterial urinary tract 
infection
II. Chronic bacterial prostatitis Caused by chronic bacterial infection of the prostate with or without symptoms of prostatitis and usually 
with recurrent urinary tract infections caused by the same bacterial strain
III. Chronic pelvic pain 
syndrome*
Characterized by symptoms of chronic pelvic pain and possibly symptoms on voiding in the absence of 
urinary tract infection
IV. Asymptomatic inflammatory 
prostatitis
Characterized by evidence of inflammation of the prostate in the absence of genitourinary tract symptoms; 
an incidental finding during evaluation for other conditions, such as infertility or elevated serum prostate- 
specific antigen levels
*
This category is subdivided into inflammatory (category IIIA) and noninflammatory (Category B) prostatitis.
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Table 2
Characteristics of the Responding Physicians (n= 289)
Characteristic
Years since graduation from medical school (mean, SD) 18.9 ± 10.8
Percentage of professional time devoted to clinical practice (mean %) 72.8 %
Practice setting
 Community-based 37.7 %
 Hospital-based 39.9 %
 Office-based/Private practice 22.3 %
Percent of patients that are male (mean, SD) 37.8 ± 31.9
Gender
 Male 53.1 %
 Female 46.9 %
Race/ethnicity
 Hispanic or Latino 5.5 %
 White 64.9 %
 Black or African American 5.9 %
 Asian 22.5 %
 American Indian or Alaska Native 0.4 %
 Native Hawaiian or Pacific Islander 0.7 %
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Table 3
Reported Frequency of Primary Care Physicians’ Performing Diagnostic Tests in the Evaluation of a Patient 
with Symptoms Suggestive of CP/CPPS* (n= 180).
I refer to a specialist at this point
 Almost always 9.3 %
 More than half the time 15.7 %
 About half the time 16.3 %
 Less than half the time 19.8 %
 Rarely 29.7 %
 Never 9.3 %
I obtain testing for Chlamydia and gonorrhea
 Almost always 70.6 %
 More than half the time 15.6 %
 About half the time 5.0 %
 Less than half the time 6.1 %
 Rarely 1.7 %
 Never 1.1 %
I order post void residual
 Almost always 4.5 %
 More than half the time 6.8 %
 About half the time 6.2 %
 Less than half the time 17.5 %
 Rarely 33.9 %
 Never 31.1 %
I order serum creatinine
 Almost always 39.9 %
 More than half the time 19.1 %
 About half the time 9.6 %
 Less than half the time 8.4 %
 Rarely 15.7 %
 Never 7.3 %
I order abdominal/pelvic CT scan
 Almost always 4.0 %
 More than half the time 6.2 %
 About half the time 9.6 %
 Less than half the time 10.7 %
 Rarely 47.5 %
 Never 22.0 %
I obtain pre- and post- prostate massage urine cultures
 Almost always 12.4 %
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 More than half the time 10.7 %
 About half the time 7.3 %
 Less than half the time 8.5 %
 Rarely 27.1 %
 Never 33.9 %
I order serum prostate specific antigen test
 Almost always 21.7 %
 More than half the time 18.9 %
 About half the time 8.6 %
 Less than half the time 9.1 %
 Rarely 21.1 %
 Never 20.6 %
I order a prostate ultrasound
 Almost always 2.3 %
 More than half the time 5.7 %
 About half the time 10.3 %
 Less than half the time 14.3 %
 Rarely 33.7 %
 Never 33.7 %
Perform any other procedure
 Yes 5 %
 No 95 %
*Chronic Prostatitis/Chronic Pelvic Pain Syndrome
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Table 4
Reported Frequency of Primary Care Physicians’ Treatment Recommendations for a Patient with Symptoms 
Suggestive of CP/CPPS* (n= 180)
Antibiotics
 Almost all 36.5 %
 More than half 35.4 %
 About half 11.2 %
 Less than half 7.3 %
 Very few 4.5 %
 None 5.1 %
Alpha blockers
 Almost all 2.3 %
 More than half 19.4 %
 About half 19.4 %
 Less than half 13.7 %
 Very few 21.1
 None 24.0
Anti-inflammatory medications
 Almost all 16.5 %
 More than half 29.5 %
 About half 15.3 %
 Less than half 9.7 %
 Very few 15.3 %
 None 13.6 %
Anti-depressant medications
 Almost all 0.6 %
 More than half 2.3 %
 About half 8.5 %
 Less than half 14.1 %
 Very few 32.2 %
 None 42.4 %
Anticholinergics (e.g., oxybutynin)
 Almost all 0.6 %
 More than half 4.0 %
 About half 5.1 %
 Less than half 15.3 %
 Very few 34.5 %
 None 40.7 %
Anticonvulsants (e.g., neurontin)
 About half 1.7 %
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 Less than half 2.8 %
 Very few 29.5 %
 None 65.9 %
Narcotic pain medications
 About half 0.6 %
 Less than half 2.3 %
 Very few 21.1 %
 None 76.0 %
Complementary/alternative medicine therapies
 Almost all 1.1 %
 More than half 1.7 %
 About half 2.8 %
 Less than half 10.2 %
 Very few 26.1 %
 None 58.0 %
Bladder analgesics (e.g., pyridium)
 Almost all 1.7 %
 More than half 2.8 %
 About half 5.6 %
 Less than half 11.3 %
 Very few 25.4 %
 None 53.1 %
5 Alpha Reductase Inhibitors
 Almost all 0.6 %
 More than half 0.6 %
 About half 6.3 %
 Less than half 6.3 %
 Very few 18.9 %
 None 67.4 %
Pelvic floor physical therapy
 More than half 2.3 %
 About half 2.3 %
 Less than half 4.5 %
 Very few 20.5 %
 None 70.5 %
Prostate massage
 More than half 1.7 %
 About half 2.8 %
 Less than half 2.8 %
 Very few 16.5 %
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 None 76.1 %
Other
 Yes 4.5 %
 No 95.5 %
*Chronic Prostatitis/Chronic Pelvic Pain Syndrome
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Table 5
Physician Knowledge and Perception of Managing Patients with CP/CPPS* (n=289)
Number of male patients that carry the diagnosis (mean, SD) 3.39 ± 5.159
Familiarity with the condition of chronic prostatitis/chronic pelvic pain syndrome in men
 Very familiar 6.6 %
 Somewhat familiar 45.6 %
 A little bit familiar 31.4 %
 Not at all familiar 16.4 %
The “hallmark” symptom of chronic prostatitis/chronic pelvic pain syndrome
 Pelvic Area Pain (correct answer) 64.4 %
 Urinary Frequency 13.8 %
 Nocturia 1.1 %
 Other 2.7 %
 I do not know 18.0 %
Familiarity with the NIH classification of prostatitis
 Very familiar 2.2 %
 Somewhat familiar 16.4 %
 A little bit familiar 33.5 %
 Not at all familiar 48.0 %
The majority of cases of chronic prostatitis/chronic pelvic pain syndrome in men are Non-infectious (correct answer)
 Strongly disagree 1.5 %
 Disagree 15.2 %
 Agree 44.6 %
 Strongly agree 26.8 %
 I don’t know 11.9 %
Caused by sexually transmitted diseases (incorrect answer)
 Strongly disagree 14.7 %
 Disagree 48.5 %
 Agree 20.3 %
 Strongly agree 3.8 %
 I don’t know 12.8 %
Caused by psychiatric illness (incorrect answer)
 Strongly disagree 15.5 %
 Disagree 49.1 %
 Agree 14.3 %
 Strongly agree 1.5 %
 I don’t know 19.6 %
*Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Prostate Cancer Prostatic Dis. Author manuscript; available in PMC 2009 September 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
EA et al. Page 19
Table 6
Reported Frequency of Primary Care Physicians’ Managing Chronic Conditions (n=289)
Chronic headache
 Frequently 77.4 %
 Sometimes 21.5 %
 Never 1.1 %
Chronic low back pain
 Frequently 92.6 %
 Sometimes 7.0 %
 Never 0.4 %
Chronic fatigue syndrome
 Frequently 23.9 %
 Sometimes 67.2 %
 Never 9.0 %
Chronic postatitis/chronic pelvic pain syndrome
 Frequently 5.6 %
 Sometimes 71.3 %
 Never 23.1 %
Interstitial cystitis/painful bladder syndrome
 Frequently 7.1 %
 Sometimes 75.8 %
 Never 17.1 %
Irritable bowel syndrome
 Frequently 61.3 %
 Sometimes 38.3 %
 Never 0.4 %
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Table 7
Physician characteristics that significantly predict familiarity and knowledge with CP/CPPS* and etiology and 
symptoms
Statistic p-value
Physician characteristics that significantly predict familiarity with CP/CPPS in men
 Practice setting X2= 8.67 df= 2 n=268 0.013
 Gender X2=38.61 df=3 n=270 0.000
 Years of practice F=4.26 df=3 n=267 0.006
 Percent of patients that are male F=12.43 df=3 n=266 0.000
Physician characteristics that significantly predict knowledge of hallmark symptom of CP/CPPS
 Gender X2= 6.63 df= 1 n=259 0.01
Physician characteristics that predict knowledge about managing patients with CP/CPPS
CP/CPPS is non-infectious
 Years of practice T=−2.00 df=158.4 n=265 0.046
 Percent of patients that are male T=−2.27 df= 262 n=264 0.024
CP/CPPS is caused by STD
 Gender X2=6.48 df=1 n=264 0.011
 Percent of patients that are male T=−2.74 df=259 n=261 0.007
*Chronic Prostatitis/Chronic Pelvic Pain Syndrome
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